A hypothesis connecting dysgeusia due to defects in ATP-P2X3 signaling and fatigue in myalgic encephalomyelitis/chronic fatigue syndrome: lessons learned from long-COVID. [PDF]
Front Med (Lausanne)Srinivasan M, Joseph PV.
europepmc +1 more source
On-target, off-tumor oral toxicities of talquetamab in heavily pretreated multiple myeloma. [PDF]
Support Care CancerAlves FA +5 more
europepmc +1 more source
Adverse oral effects of GLP-1 and GIP receptor agonists: a scoping review protocol. [PDF]
BMJ OpenEscudero Samaniego DG +8 more
europepmc +1 more source
Effect of Taste Recall Training in an Older Adult With Depression and Sarcopenia Presenting With Dysgeusia: A Case Report. [PDF]
Geriatr Gerontol IntMiyagi M +7 more
europepmc +1 more source
Safety, Tolerability, and Pharmacokinetics of Oral Camlipixant: A Randomized First-In-Human Study Using Single and Multiple Ascending Doses. [PDF]
J Clin PharmacolChauret N +6 more
europepmc +1 more source
Associations Between Nasal Receptors and Olfactory Dysfunction and Dysgeusia in Coronavirus Disease 2019 (COVID-19). [PDF]
J Clin MedPiqueras-Sánchez AM +8 more
europepmc +1 more source
Management of Patients Undergoing Chemotherapy in Conservative Dentistry. [PDF]
CureusDerras B, Bassim N.
europepmc +1 more source
Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis. [PDF]
JTO Clin Res RepVitale E +4 more
europepmc +1 more source
Efficacy and safety of vismodegib in periocular and orbital basal cell carcinoma: a systematic review and meta-analysis. [PDF]
Front Med (Lausanne)Alessa D.
europepmc +1 more source